Δ133p53α and Δ160p53α isoforms of the tumor suppressor protein p53 exert dominant-negative effect primarily by co-aggregation
p53 is a tumor suppressor protein with multiple isoforms with shared or specific functions. However, two of its isoforms, Δ133p53α and Δ160p53α, with large N-terminal deletions, can cause cancer. These isoforms exert a dominant-negative effect on full-length p53 (FLp53), although the precise molecul...
Saved in:
| Main Authors: | Liuqun Zhao, Tanel Punga, Suparna Sanyal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
eLife Sciences Publications Ltd
2025-07-01
|
| Series: | eLife |
| Subjects: | |
| Online Access: | https://elifesciences.org/articles/106469 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TP53 drives invasion through expression of its Δ133p53β variant
by: Gilles Gadea, et al.
Published: (2016-09-01) -
Discovery of Drugs Targeting Mutant p53 and Progress in Nano-Enabled Therapeutic Strategy for p53-Mutated Cancers
by: Na Zhang, et al.
Published: (2025-05-01) -
In-frame germline TP53 variant impairs p53 oligomerization and predisposes to cancer
by: Lucie Vanikova, et al.
Published: (2025-08-01) -
p53 in colorectal cancer: from a master player to a privileged therapy target
by: Sicheng Yan, et al.
Published: (2025-06-01) -
Neoplasias astrocitárias e correlação com as proteínas p53 mutada e Ki-67 Astrocytic neoplasms and correlation with mutate p53 and Ki-67 proteins
by: Gustavo Rassier Isolan, et al.
Published: (2005-12-01)